StreetInsider.com News Articles

Form 4 CASTLE BIOSCIENCES INC For: Aug 25 Filed by: Juvenal Tobin W

Thu, 27 Aug 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260827/26990681.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 25 Filed by: Juvenal Tobin W

Thu, 27 Aug 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260827/26990681.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 24 Filed by: Oelschlager Kristen M

Wed, 26 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260826/26982026.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 24 Filed by: Oelschlager Kristen M

Wed, 26 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260826/26982026.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 17 Filed by: Juvenal Tobin W

Tue, 25 Aug 2026 19:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26976005.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 17 Filed by: Juvenal Tobin W

Tue, 25 Aug 2026 19:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26976005.html

Form 144 CASTLE BIOSCIENCES INC Filed by: Juvenal Tobin W

Tue, 25 Aug 2026 17:46:00 -0400

si-local-file:///var/storage/secattach/20260825/26975871.html

Form 144 CASTLE BIOSCIENCES INC Filed by: Juvenal Tobin W

Tue, 25 Aug 2026 17:46:00 -0400

si-local-file:///var/storage/secattach/20260825/26975871.html

Form 144 CASTLE BIOSCIENCES INC Filed by: Oelschlager Kristen M

Mon, 24 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260824/26968758.html

Form 144 CASTLE BIOSCIENCES INC Filed by: Oelschlager Kristen M

Mon, 24 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260824/26968758.html

Castle Biosciences to Participate in Upcoming Investor Conferences

Thu, 20 Aug 2026 07:00:00 -0400

FRIENDSWOOD, Texas, Aug. 20, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at Baird's 2026 Global Healthcare Conference on Tuesday, Sept. 15, 2026, at 10:50 a.m. Eastern time.

A live audio webcast of the Company's presentation will be available by visiting Castle Biosciences' website at https://ir.castlebiosciences.com/news-events/ir-events. A replay of the webcast will be available following the conclusion of the

Castle Biosciences to Participate in Upcoming Investor Conferences

Thu, 20 Aug 2026 07:00:00 -0400

Castle Biosciences to Participate in Upcoming Investor Conferences

Thu, 20 Aug 2026 07:00:00 -0400

Castle Biosciences to Participate in Upcoming Investor Conferences

Thu, 20 Aug 2026 07:00:00 -0400

Form 4 CASTLE BIOSCIENCES INC For: Aug 17 Filed by: Juvenal Tobin W

Wed, 19 Aug 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260819/26950174.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 17 Filed by: Juvenal Tobin W

Wed, 19 Aug 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260819/26950174.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 14 Filed by: Stokes Frank

Tue, 18 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260818/26944310.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 14 Filed by: Stokes Frank

Tue, 18 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260818/26944310.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 14 Filed by: MAETZOLD DEREK J

Tue, 18 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260818/26944297.html

Form 4 CASTLE BIOSCIENCES INC For: Aug 14 Filed by: MAETZOLD DEREK J

Tue, 18 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260818/26944297.html

Castle Biosciences gains dual listing on Nasdaq Texas

Mon, 17 Aug 2026 07:00:51 -0400

Castle Biosciences, Inc. (Nasdaq: CSTL) has been approved to dual-list its common stock on Nasdaq Texas, a newly established exchange headquartered in Dallas, according to a company statement.

The Friendswood, Texas-based diagnostics company will maintain its primary listing on the Nasdaq Global Market while trading under its existing ticker symbol "CSTL" on the new exchange.

Nasdaq Texas is designed to support public companies with ties to Texas, while allowing issuers to retain access to Nasdaq's global platform, technology and market infrastructure.

The company said the dual listing will not affect investors' ability to buy or sell Castle's common stock, nor will it impact

Castle Biosciences gains dual listing on Nasdaq Texas

Mon, 17 Aug 2026 07:00:51 -0400

Castle Biosciences, Inc. (Nasdaq: CSTL) has been approved to dual-list its common stock on Nasdaq Texas, a newly established exchange headquartered in Dallas, according to a company statement.

The Friendswood, Texas-based diagnostics company will maintain its primary listing on the Nasdaq Global Market while trading under its existing ticker symbol "CSTL" on the new exchange.

Nasdaq Texas is designed to support public companies with ties to Texas, while allowing issuers to retain access to Nasdaq's global platform, technology and market infrastructure.

The company said the dual listing will not affect investors' ability to buy or sell Castle's common stock, nor will it impact

Castle Biosciences Approved for Dual Listing on Nasdaq Texas

Mon, 17 Aug 2026 07:00:00 -0400

FRIENDSWOOD, Texas, Aug. 17, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been approved to have its common stock dually listed on Nasdaq Texas, a new exchange headquartered in Dallas. Castle will maintain its primary listing on The Nasdaq Global Market, and its common stock is expected to begin listing on Nasdaq Texas today under its existing ticker symbol, "CSTL."

"Castle was founded in Texas and remains deeply connected to

Castle Biosciences Approved for Dual Listing on Nasdaq Texas

Mon, 17 Aug 2026 07:00:00 -0400

"Castle was founded in Texas and remains deeply connected to

Castle Biosciences Approved for Dual Listing on Nasdaq Texas

Mon, 17 Aug 2026 07:00:00 -0400

"Castle was founded in Texas and remains deeply connected to